Skip to main content
Top
Published in: Journal of Thrombosis and Thrombolysis 2/2022

01-02-2022 | Cardiogenic Shock

Impact of COVID-19 outbreak on patients with ST-segment elevation myocardial ınfarction (STEMI) in Turkey: results from TURSER study (TURKISH St-segment elevation myocardial ınfarction registry)

Authors: Tuncay Kiris, Eyüp Avci, Tuba Ekin, Didar Elif Akgün, Mücahit Tiryaki, Arafat Yidirim, Kutluhan Hazir, Bektaş Murat, Mehtap Yeni, Rojhad Altindag, Sefa Gül, Baran Arik, Tuncay Güzel, Selda Murat, Ahmet Oz, Mustafa Karabacak, Zihni Aktas, Tarik Yildirim, Baris Kilicaslan, Asim Oktay Ergene

Published in: Journal of Thrombosis and Thrombolysis | Issue 2/2022

Login to get access

Abstract

Objective

We aimed to investigate both the impact of COVID-19 pandemic on ST-segment elevation myocardial infarction (STEMI) admission, and demographic, angiographic, procedural characteristics, and in-hospital clinical outcomes of patients with COVID-19 positive STEMI in Turkey.

Methods

This was a multi-center and cross-sectional observational study. The study population included 1788 STEMI patients from 15 centers in Turkey. The patients were divided into two groups: COVID-19 era (March 11st–May 15st, 2020; n = 733) or pre- COVID-19 era group (March 11st–May 15st, 2019; n = 1055). Also, the patients in COVID-19 era were grouped as COVID-19 positive (n = 65) or negative (n = 668).

Results

There was a 30.5% drop in STEMI admission during COVID-19 era in comparison to pre-COVID-19 era. The patients admitted to the medical centers during COVID-19 era had a longer symptom-to-first medical contact time [120 (75–240) vs. 100 (60–180) minutes, p < 0.001]. COVID-19 positive STEMI patients had higher thrombus grade and lower left ventricular ejection fraction compared to COVID-19 negative patients. COVID-19 positive patients had higher mortality (28% vs. 6%, p < 0.001) and cardiogenic shock (20% vs. 7%, p < 0.001) rates compared with those without COVID-19. Matching based on propensity scores showed higher mortality and high thrombus grade in STEMI patients who were infected by SARS-COV-2 (each p < 0.05).

Conclusions

We detected significantly lower STEMI hospitalization rates and significant delay in duration of symptom onset to first medical contact in the context of Turkey during the COVID-19 outbreak. Moreover, high thrombus grade and mortality were more common in COVID-19 positive STEMI patients.
Appendix
Available only for authorised users
Literature
1.
go back to reference Onder G, Rezza G, Brusaferro S (2020) Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA 323(18):1775–1776PubMed Onder G, Rezza G, Brusaferro S (2020) Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA 323(18):1775–1776PubMed
2.
go back to reference De Rosa S, Spaccarotella C, Basso C, SocietàItaliana di Cardiologia and the CCU Academy investigators group et al (2020) Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era. Eur Heart J 41(22):2083–2088CrossRefPubMed De Rosa S, Spaccarotella C, Basso C, SocietàItaliana di Cardiologia and the CCU Academy investigators group et al (2020) Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era. Eur Heart J 41(22):2083–2088CrossRefPubMed
3.
go back to reference Nallamothu BK, Normand S-LT, Wang Y et al (2015) Relation between door-to balloon times and mortality after primary percutaneous coronary intervention over time: a retrospective study. Lancet 385(9973):1114–1122CrossRefPubMed Nallamothu BK, Normand S-LT, Wang Y et al (2015) Relation between door-to balloon times and mortality after primary percutaneous coronary intervention over time: a retrospective study. Lancet 385(9973):1114–1122CrossRefPubMed
4.
go back to reference Guerchicoff A, Brener SJ, Maehara A et al (2014) Impact of delay to reperfusion on reperfusion success, infarct size, and clinical outcomes in patients with ST segment elevation myocardia linfarction: the INFUSE-AMI trial (INFUSE anterior myocardial infarction). JACC Cardiovasc Interv 7(7):733–740CrossRefPubMed Guerchicoff A, Brener SJ, Maehara A et al (2014) Impact of delay to reperfusion on reperfusion success, infarct size, and clinical outcomes in patients with ST segment elevation myocardia linfarction: the INFUSE-AMI trial (INFUSE anterior myocardial infarction). JACC Cardiovasc Interv 7(7):733–740CrossRefPubMed
5.
go back to reference Bikdeli B, Madhavan MV, Jimenez D et al (2020) COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up. J Am Coll Cardiol 75:2950–2973CrossRefPubMedPubMedCentral Bikdeli B, Madhavan MV, Jimenez D et al (2020) COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up. J Am Coll Cardiol 75:2950–2973CrossRefPubMedPubMedCentral
7.
go back to reference Hartikainen TS, So¨rensen NA, Haller PM et al (2020) Clinical application of the 4th universal definition of myocardial ınfarction. Eur Heart J 41(23):2209–2216CrossRefPubMed Hartikainen TS, So¨rensen NA, Haller PM et al (2020) Clinical application of the 4th universal definition of myocardial ınfarction. Eur Heart J 41(23):2209–2216CrossRefPubMed
8.
go back to reference Ibanez B, James S, Agewall S et al (2018) 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial in. Eur Heart J 00(2):119–177CrossRef Ibanez B, James S, Agewall S et al (2018) 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial in. Eur Heart J 00(2):119–177CrossRef
9.
go back to reference Sianos G, Papafaklis MI, Serruys PW (2010) Angiographic thrombus burden classification in patients with ST-segment elevation myocardial infarction treated with percutaneous coronary intervention. J Invasive Cardiol 22:6B-14BPubMed Sianos G, Papafaklis MI, Serruys PW (2010) Angiographic thrombus burden classification in patients with ST-segment elevation myocardial infarction treated with percutaneous coronary intervention. J Invasive Cardiol 22:6B-14BPubMed
10.
go back to reference Gibson CM, de Lemos JA, Murphy SA, Marble SJ, McCabe CH, Cannon CP, Antman EM, Braunwald E (2001) Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy. Circulation 103:2550–2554CrossRefPubMed Gibson CM, de Lemos JA, Murphy SA, Marble SJ, McCabe CH, Cannon CP, Antman EM, Braunwald E (2001) Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy. Circulation 103:2550–2554CrossRefPubMed
11.
go back to reference Patel A, Jernigan DB (2020) Initial public health response and interim clinical guidance for the 2019 novel coronavirus outbreak—United States, December 31, 2019-February 4, 2020. MMWR Morb Mortal Wkly Rep 69(5):140–146CrossRefPubMedPubMedCentral Patel A, Jernigan DB (2020) Initial public health response and interim clinical guidance for the 2019 novel coronavirus outbreak—United States, December 31, 2019-February 4, 2020. MMWR Morb Mortal Wkly Rep 69(5):140–146CrossRefPubMedPubMedCentral
13.
go back to reference Garcia S, Albaghdadi MS, Meraj PM et al (2020) Reduction in ST segment elevation cardiac catheterization laboratory activations in the United States during COVID-19 pandemic. J Am Coll Cardiol 75(22):2871–2872CrossRefPubMedPubMedCentral Garcia S, Albaghdadi MS, Meraj PM et al (2020) Reduction in ST segment elevation cardiac catheterization laboratory activations in the United States during COVID-19 pandemic. J Am Coll Cardiol 75(22):2871–2872CrossRefPubMedPubMedCentral
14.
go back to reference Rodriguez-Leor O, Cid-Alvarez B, Ojeda S et al (2020) Impacto de la pandemia de COVID-19 sobre la actividad asistencialen cardiologia intervencionista en Espana. REC Interv Cardiol 155(4):179–180 Rodriguez-Leor O, Cid-Alvarez B, Ojeda S et al (2020) Impacto de la pandemia de COVID-19 sobre la actividad asistencialen cardiologia intervencionista en Espana. REC Interv Cardiol 155(4):179–180
15.
go back to reference Abdelaziz HK, Abdelrahman A, Nabi A et al (2020) Impact of COVID-19 pandemic on patients with ST-segment elevation myocardial infarction: insights from a British cardiac center. Am Heart J 226:45–48CrossRefPubMedPubMedCentral Abdelaziz HK, Abdelrahman A, Nabi A et al (2020) Impact of COVID-19 pandemic on patients with ST-segment elevation myocardial infarction: insights from a British cardiac center. Am Heart J 226:45–48CrossRefPubMedPubMedCentral
16.
go back to reference Erol MK, Kayıkçıoğlu M, Kılıçkap M et al (2020) Treatment delays and in-hospital outcomes in acute myocardial infarction during the COVID-19 pandemic: a nationwide study. Anatol J Cardiol 24(5):334–342PubMedPubMedCentral Erol MK, Kayıkçıoğlu M, Kılıçkap M et al (2020) Treatment delays and in-hospital outcomes in acute myocardial infarction during the COVID-19 pandemic: a nationwide study. Anatol J Cardiol 24(5):334–342PubMedPubMedCentral
17.
go back to reference Brook RD, Sanjay Rajagopalan C, Pope A et al (2010) Particulate matter air pollution and cardiovascular disease. Circulation 121(21):2331–2378CrossRefPubMed Brook RD, Sanjay Rajagopalan C, Pope A et al (2010) Particulate matter air pollution and cardiovascular disease. Circulation 121(21):2331–2378CrossRefPubMed
18.
go back to reference PhilipJ Landrigan R, Fuller NA et al (2018) The lancet commission on pollution and health. Lancet 391(10119):462–512CrossRef PhilipJ Landrigan R, Fuller NA et al (2018) The lancet commission on pollution and health. Lancet 391(10119):462–512CrossRef
19.
go back to reference Patik JC, Tucker WJ, Curtis BM, Nelson MD, Nasirian A, Park S, Brothers RM (2018) Fast-food meal reduces peripheral artery endothelial function but not cerebralvascular hypercapnic reactivity in healthy young men. Physiol Rep 6(18):e13867CrossRefPubMedPubMedCentral Patik JC, Tucker WJ, Curtis BM, Nelson MD, Nasirian A, Park S, Brothers RM (2018) Fast-food meal reduces peripheral artery endothelial function but not cerebralvascular hypercapnic reactivity in healthy young men. Physiol Rep 6(18):e13867CrossRefPubMedPubMedCentral
20.
go back to reference Kivimäki M, Jokela M, Nyberg ST, IPD-Work Consortium et al (2015) Long working hours and risk of coronary heart disease and stroke: a systematic review and meta-analysis of published and unpublished data for 603,838 individuals. Lancet 386(10005):1739–46CrossRefPubMed Kivimäki M, Jokela M, Nyberg ST, IPD-Work Consortium et al (2015) Long working hours and risk of coronary heart disease and stroke: a systematic review and meta-analysis of published and unpublished data for 603,838 individuals. Lancet 386(10005):1739–46CrossRefPubMed
21.
go back to reference Nyberg ST, Singh-Manoux A, Pentti J et al (2020) Association of healthy lifestyle with years lived without major chronic diseases. JAMA Intern Med 180(5):1–10CrossRefPubMedCentral Nyberg ST, Singh-Manoux A, Pentti J et al (2020) Association of healthy lifestyle with years lived without major chronic diseases. JAMA Intern Med 180(5):1–10CrossRefPubMedCentral
22.
23.
go back to reference De Luca G, Suryapranata H, Ottervanger JP, Antman EM (2004) Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts. Circulation 109(10):1223–1225CrossRefPubMed De Luca G, Suryapranata H, Ottervanger JP, Antman EM (2004) Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts. Circulation 109(10):1223–1225CrossRefPubMed
26.
go back to reference Fan BE, Chong VCL, Chan SSW et al (2020) Hematologic parameters in patients with COVID-19 infection. Am J Hematol 95:e131–e134CrossRefPubMed Fan BE, Chong VCL, Chan SSW et al (2020) Hematologic parameters in patients with COVID-19 infection. Am J Hematol 95:e131–e134CrossRefPubMed
27.
go back to reference Klok FA, Kruip MJHA, van der Meer NJM et al (2020) Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res 191:145–147CrossRefPubMedPubMedCentral Klok FA, Kruip MJHA, van der Meer NJM et al (2020) Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res 191:145–147CrossRefPubMedPubMedCentral
28.
go back to reference Tang N, Li D, Wang X, Sun Z (2020) Abnormal coagulation parameters are associated with poorprognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 18:844–847CrossRefPubMedPubMedCentral Tang N, Li D, Wang X, Sun Z (2020) Abnormal coagulation parameters are associated with poorprognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 18:844–847CrossRefPubMedPubMedCentral
29.
go back to reference Beyrouti R, Adams ME, Benjamin L et al (2020) Characteristics of ischaemic stroke associated with COVID-19. J Neurol Neurosurg Psychiatry 91(8):889–891CrossRefPubMed Beyrouti R, Adams ME, Benjamin L et al (2020) Characteristics of ischaemic stroke associated with COVID-19. J Neurol Neurosurg Psychiatry 91(8):889–891CrossRefPubMed
31.
go back to reference Kwong JC, Schwartz KL, Campitelli MA et al (2018) Acute myocardial infarction after laboratory-confirmed influenza infection. N Engl J Med 378:345–353CrossRefPubMed Kwong JC, Schwartz KL, Campitelli MA et al (2018) Acute myocardial infarction after laboratory-confirmed influenza infection. N Engl J Med 378:345–353CrossRefPubMed
Metadata
Title
Impact of COVID-19 outbreak on patients with ST-segment elevation myocardial ınfarction (STEMI) in Turkey: results from TURSER study (TURKISH St-segment elevation myocardial ınfarction registry)
Authors
Tuncay Kiris
Eyüp Avci
Tuba Ekin
Didar Elif Akgün
Mücahit Tiryaki
Arafat Yidirim
Kutluhan Hazir
Bektaş Murat
Mehtap Yeni
Rojhad Altindag
Sefa Gül
Baran Arik
Tuncay Güzel
Selda Murat
Ahmet Oz
Mustafa Karabacak
Zihni Aktas
Tarik Yildirim
Baris Kilicaslan
Asim Oktay Ergene
Publication date
01-02-2022
Publisher
Springer US
Published in
Journal of Thrombosis and Thrombolysis / Issue 2/2022
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-021-02487-3

Other articles of this Issue 2/2022

Journal of Thrombosis and Thrombolysis 2/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.